MetaCap

Lakefront Biotherapeutics (LKFT) vs Prestige Consumer Healthcare (PBH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Lakefront Biotherapeutics (LKFT) has outperformed Prestige Consumer Healthcare (PBH) over the past year, gaining 8.6% versus a loss of 16.5%. Over five years, PBH leads with a -12.0% price change compared with -31.8% for LKFT. Prestige Consumer Healthcare is the larger company by market cap ($2.35 billion vs $2.18 billion), about 1.1 times the size.

On valuation, Lakefront Biotherapeutics trades at a lower trailing P/E (2.4x vs 15.3x for Prestige Consumer Healthcare).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LKFT+8.64%PBH-16.48%
+20%-5%-30%
Nov 21, 20251 yearNov 20, 2026
LKFT-35.27%PBH-14.81%
+58%-1%-61%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LKFT versus PBH key metrics
MetricLKFTPBH
Share price$33.31$49.63
Market cap$2.18B$2.35B
1-day change-0.24%+0.06%
YTD return+1.87%-19.55%
1-year return+8.64%-16.48%
5-year return-31.80%-12.02%
P/E ratio (TTM)2.3915.32
Forward P/E—9.76
EPS (TTM)$13.94$3.24
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$1.09B
Revenue growth (YoY)—-4.31%
Net income (latest FY)—$190.30M
Gross margin—54.71%
Operating margin—28.42%
Net margin—17.48%
52-week high$36.24$71.07
52-week low$25.68$41.77
Distance from 52-week high-8.08%-30.17%
Analyst consensusholdbuy
Avg. price target upside-7.39%+33.39%
Average volume280.49K583.25K
Shares outstanding65.48M47.40M
Employees196890
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • LKFT has outperformed PBH by 25.1 percentage points over the past year.
  • Prestige Consumer Healthcare trades at a higher earnings multiple (15.3x vs 2.4x trailing P/E).

About Lakefront Biotherapeutics

LKFT stock →

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma.

Health Care · Biotechnology: Pharmaceutical Preparations · 196 employees

About Prestige Consumer Healthcare

PBH stock →

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Health Care · Biotechnology: Pharmaceutical Preparations · 890 employees

LKFT vs PBH FAQ

Which is bigger, Lakefront Biotherapeutics or Prestige Consumer Healthcare?

Prestige Consumer Healthcare (PBH) is larger, with a market capitalization of $2.35B compared with $2.18B for Lakefront Biotherapeutics (LKFT).

Which stock has performed better over the past year, LKFT or PBH?

LKFT returned +8.64% over the past 12 months, compared with -16.48% for PBH (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, LKFT or PBH?

LKFT has the lower trailing P/E at 2.4, versus 15.3 for PBH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Lakefront Biotherapeutics and Prestige Consumer Healthcare in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons